Repression of transcription by nuclear receptors involves NCOR and SMRT corepressor complexes, which harbour the deacetylase HDAC3 as a subunit. Both deacetylase-dependent and -independent repression mechanisms have been reported for these complexes. In the absence of ligands, the nuclear receptor PPARβ/δ recruits NCOR and SMRT and represses expression of its canonical targets including the ANGPTL4 gene. Agonistic ligands cause corepressor dissociation and enable enhanced induction of transcription by coactivators. Vice versa, recently developed synthetic inverse agonists lead to augmented corepressor recruitment and repression that dominates over activating stimuli.
Introduction
PPARβ/δ (peroxisome proliferator activated receptor β/δ) is a type II nuclear receptor which constitutively binds to DNA as an obligate heterodimer with a retinoid X receptor (RXR). Its target genes function in lipid and glucose metabolism and also in inflammation [1, 2] . An important PPAR target gene is ANGPTL4 (angiopoietin-like 4), a regulator of lipid metabolism, angiogenesis, wound healing, and metastasis [3, 4] . In the absence of ligands, the PPARβ/δ-RXR heterodimer represses its canonical target genes [1] via the recruitment of corepressors [5] such as NCOR (nuclear receptor corepressor)-and SMRT (silencing mediator of retinoid and thyroid hormone receptors)-containing complexes [6, 7] , which both harbour the catalytic subunit histone deacetylase 3 (HDAC3) [8] whose activity requires binding to NCOR or SMRT [9] . Several fatty acids and their derivatives act as endogenous PPARβ/δ agonists [10, 11, 12, 13] . Agonistic ligands cause dissociation of corepressors from the nuclear receptor at ligand-regulated target genes, while synthetic inverse agonists recently developed in our group lead to enhanced corepressor recruitment [4, 6, 14, 15] . Basal repression of ANGPTL4 and augmented repression in the presence of inverse agonists are largely insensitive to trichostatin A [4] , an inhibitor of class I and II HDACs, suggesting an HDAC-independent repression mechanism. Induction of ANGPTL4 transcription by activating stimuli is efficiently suppressed by PPARβ/δ inverse agonists, and this coincides with decreased binding of RNA polymerase II (RNAPII) [4] . Agonists alleviate basal repression, and transcription is induced synergistically with other activating stimuli 
Materials and methods Antibodies

ChIP-mass spectrometry (ChIP-MS)
Two technical replicates each were performed by Active Motif Epigenetic Services according to a published protocol [26] from the following MDA-MB231-luc2 samples: IgG, PT-S264 treatment (0.3 µM); α-PPARβ/δ, PT-S264 treatment (0.3 µM); α-PPARβ/δ, L165,041 treatment (1.0 µM). The unspecific IgG pool from rabbit was obtained from Sigma-Aldrich (no. I5006), the PPARβ/δ antibody from Santa Cruz Biotechnology (sc-7197, rabbit polyclonal). Candidate proteins were filtered with scaffold Viewer 4.8.3 (Proteome Software) according to the following criteria: At least two unique peptides in total and a maximum of two unique peptides each in the negative control replicates (IgG). The protein and the peptide thresholds were each set to 80 %. 
RNA isolation, cDNA synthesis, and quantitative RT-PCR
Chromatin immunoprecipitation (ChIP)-qPCR
ChIP was essentially performed as described previously [27, 28] . Fixation was performed with 1 % formaldehyde in media for 10 min at room temperature followed by quenching with 125 mM glycin for 5 min. 
Genetic deletion and stable transfection
Vectors for parallel expression of a guide RNA and the Cas9 nuclease were obtained from Santa Cruz Biotechnology.
The sequences targeting the PPARD coding region were CCCTGTGCAGCTATCCGTTT (1), AACACTCACCGCCGTGTGGC (2), and TCGTACGATCCGCATGAAGC (3). MDA-MB231-luc2 cells were transfected using Lipofectamine 2000 (Life Technologies) according to the manufacturer's instructions with the guide/Cas9 expression vectors together with pMSCVbsd [29] for selection of transfected cells. After four hours, the cells were supplemented with fresh medium, and blasticidin was added after 30 hours at a concentration of 10 µg/ml. After ten days, single cells were seeded using limiting 7/39 dilution in cell-free medium conditioned by the parental cell line. Wells with more than one colony were terminated.
Clones were expanded and screened via RT-qPCR (loss of ANGPTL4 repression by PT-S264) and immunoblotting.
The 2B3 clone was transfected with pWZLneo-ecoR [30] . After 24 hours, the cells were selected with 500 µg/ml G418 for 14 days.
PPARD expression vectors
The retroviral vector pMSCVbsd [29] was used to clone the PPARD cDNA using the BglII and XhoI sites. Deletions were introduced via PCR with specific primers, and the fragment was re-inserted into the empty pMSCVbsd vector.
Alterations in the cDNA sequence were introduced with site-directed mutagenesis. Vectors are available upon request.
Retroviral transduction
For production of ecotropic retroviruses, pMSCVbsd-PPARD vectors or the empty vector were transfected into subconfluent ϕNX packaging cells [24] . After four hours, 7 ml of fresh medium were added. Twenty-four hours later, the supernatant was harvested, centrifuged at 800×g, and 3 ml aliquots were snap frozen. The ϕNX cells received fresh medium, and a second supernatant was harvested 24 hours later. Freshly seeded MDA-MB231-luc2-2B3 cells ectopically expressing the ecotropic receptor were incubated with 2 ml of fresh medium, 3 ml of ϕNX supernatant, and 4 µg/ml polybrene for 24 hours. Selection was performed with 10 µg/ml blasticidin for ten days, and cells were subsequently cultured in the presence of blasticidin.
Results
PPARβ/δ inverse agonists interfere with formation of an initiation complex
PT-S264 is an inverse PPARβ/δ agonist with improved repressive properties and stability [15] . We first tested whether it affects initiation complex formation like the previously used inverse agonist ST247 [25] , which reduces RNAPII binding to the ANGPTL4 promoter [4] . Treatment with PT-S264 diminished RNAPII binding to the ANGPTL4 TSS at the TSS. Caki-1 cells highly express ANGPTL4 [4] and hence allow for ChIP-based detection of GTFs at the endogenous locus. To address which step of initiation complex formation was affected, we measured the occupancy of GTFs and Mediator at the ANGPTL4 TSS in the presence or in the absence of PPARβ/δ inverse agonists. PT-S264 impedes binding of TFIIB and RNAPII. Yet, GTFs are present, indicating that the TSS is accessible ( fig. 1B ). Since the occupancy of TFIIA was not altered, we postulate that the repressive mechanism affects the transition from the scaffold complex to the RIC; PIC formation may be impaired too, which cannot be inferred from these data obtained after short-term treatment. TSC22D3 is not a PPAR target gene; reduced TFIIB and RNAPII occupancy were not observed at its TSS upon treatment with the inverse agonist PT-S264. In the presence of TGFβ, TFIIB binding to the ANGPTL4 TSS is increased, and this is counteracted by PT-S264 ( fig. 1C ).
The Mediator complex facilitates the rate-limiting step of TFIIB recruitment, and both Mediator and TFIIB are necessary for RNAPII binding [31] . Previous ChIP-qPCR experiments after treatment with the inverse agonist ST247
showed that both TFIIH, another GTF present in the scaffold, and MED1 (Mediator subunit 1) bind to the ANGPTL4 and is consistent with the notion that the kinase module is detected at promoters in metazoans [33] . We conclude that PPARβ/δ inverse agonists perturb transcription initiation at the ANGPTL4 TSS presumably by interfering with
Mediator-TFIIB-RNAPII recruitment to promoter-bound GTFs.
PT-S264 augments NCOR binding to PPARβ/δ
We previously found that depletion of NCOR by RNAi alleviates basal repression to the same extent as PPARβ/δ depletion but does not prevent repression by an inverse agonist [4] . However, RNAi-mediated partial depletion may not suffice for full loss of function. To identify candidate repressors in an unbiased approach, ChIP-mass spectrometry (ChIP-MS) according to the RIME (rapid immunoprecipitation and mass spectrometry of endogenous proteins) protocol [26] was performed with an antibody against PPARβ/δ (see table 1 on the following page). We used 9/39
Protein or cluster 
Eukaryotic translation initiation factor 5 EIF5 1. Table 1 . PPARβ/δ interactors in the presence of the inverse agonist PT-S264 or the agonist L165,041 (RIME ChIP-MS analysis). The numbers indicate the mean unique peptide count from two technical replicates each. The difference count is peptides(PT-S264)-peptides(L165,041) for the cognate IPs (α-PPARβ/δ). An IgG fraction from non-immunized rabbits served as a negative control. The gene names of the antibody target (PPARD) and known interactors are printed in boldface.
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chromatin from MDA-MB231-luc2 cells, in which PPARβ/δ target gene repression by inverse agonists is particularly strong (supp. fig. S2 and [4] ). PPARβ/δ and RXR were robustly identified both in the presence of the inverse agonist PT-S264 and the agonist L165,041. Importantly, NCOR (encoded by the NCOR1 gene) and SMRT (encoded by the NCOR2 gene) were identified as interactors only in the presence of PT-S264 but not in the presence of L165,041.
Other known transcriptional repressors were not detected. The NCOR2 protein cluster revealed 15 and 7 unique peptides for NCOR after treatment with PT-S264 in the two technical replicates, while only 4 and 3 peptides were identified for SMRT. This finding may indicate that NCOR binding to PPARβ/δ is dominant over SMRT binding in MDA-MB231-luc2 cells in the presence of PT-S264. Of note, TBL1XR1, a subunit of NCOR and SMRT complexes [8] , was also only detected in the presence of PT-S264 but not in the presence of L165,041.
Next, we measured NCOR binding to the PPARβ/δ binding sites (PPREs) of the target genes ANGPTL4 and PDK4 [1] in the presence and in the absence of PT-S264 by ChIP-qPCR using two different antibodies. In agreement with ChIP-MS data, NCOR was present at the ANGPTL4 PPRE. Interestingly, we found increased binding of NCOR after treatment with the inverse agonist PT-S264 both in the presence and in the absence of TGFβ ( fig. 2A ). 
A reconstitution screen identifies PPARβ/δ mutants defective in ligand response and basal repression
We were unable to obtain NCOR knockout clones in the MDA-MB231-luc2 and Caki-1 cell lines with the CRISPR-Cas9 system. In order to investigate the role of NCOR in PT-S264-mediated repression, we therefore aimed to interfere with NCOR binding to PPARβ/δ through targeted mutation of the receptor. To this end, expression of PPARβ/δ was disrupted in MDA-MB231-luc2 cells using the CRISPR increased in PPARβ/δ knockout cells (supp. fig. S4 ), suggesting that PPARα, PPARβ/δ, and PPARγ compete for the same binding sites. However, relative to wildtype cells, binding of RXR is reduced in PPARβ/δ KO cells. This finding indicates that PPARβ/δ is the main factor that binds to the PPREs of the ANGPTL4 and PDK4 genes in MDA-MB231-luc2. Consistently, both induction of the ANGPTL4 transcript by the synthetic agonist L165,041 and repression by the inverse agonist PT-S264 were disrupted in the knockout clones (supp. fig. S5 ). In contrast, the PPARγ agonist pioglitazone retained its function and stimulated ANGPTL4 expression. Surprisingly (for unknown reasons), the PPARα agonist Wy-14643 did not activate expression of the ANGPTL4 gene. (supp. fig. S5 ).
For rescue experiments with wildtype PPARβ/δ and corresponding mutants, we used the 2B3 clone, which neither showed growth defects nor stable integration of the Cas9 expression vector. Sequencing of clones from PCR fragments indicated that guide RNAs 1 and 3 resulted in single-base deletions (no. 3) or insertions (no. 1). In line with previous observations [34] , ectopic expression of PPARβ/δ driven by the strong cytomegalovirus (CMV) promoter led to formation of intracellular aggregates and failed to restore ligand function (data not shown). We stably transfected this cell clone with a vector encoding the murine ecotropic retroviral receptor [30] , allowing for ecotropic retroviral infection. The resulting 2B3-ecoR cells were then transduced with pMSCV vectors to express wildtype or mutant PPARβ/δ, driven by the comparably weak viral LTRs. Expression of the mutants was confirmed on protein level (supp. fig. S7 ). We assume that PPARβ/δ is weakly expressed in all cellular models we analysed due to low signals on both RNA and protein levels. The level of PPARβ/δ ectopically expressed from pMSCV was above that of wildtype cells ( fig. 3D ). Nevertheless, both the activation and repression functions of PPARβ/δ were restored (see fig. 4 ), albeit to lesser extent than that observed in wildtype cells (supp. fig. S6 ).
Next, we generated a panel of 67 mutants that encode for truncated proteins or proteins with one or more substitutions of amino acid residues. Preferentially, mutations of amino acids at the surface of the LBD (ligand binding domain) were used. The panel also includes a negative control, C91A-E92A "CE2A", a double mutant of residues critical for DNA binding [35] , and mutants in which the AF2 (activating function 2) domain was disrupted-leucines 429, 432, and 433 in the LXXLL motif of helix 12. These mutants should not respond to agonists. We performed a functional screen, intending to identify residues in PPARβ/δ which are necessary for basal and PT-S264-regulated repression of the ANGPTL4 gene. ANGPTL4 expression was monitored after treatment with the solvent, the inverse agonist PT-S264, or the agonist L165,041. Importantly, the ligands did not modulate ANGPTL4 expression in screen are summarised in fig. 4 . Raw expression data for all mutants are available in the supplementary material.
The positions of selected mutations referred to below are highlighted in fig. 4E . Our screen identified six types of mutations:
(i) Mutations which disrupt basal repression ( fig. 4A ). These are K421A-K422A and T427I; in cells expressing these mutants, ligand function is not generally impaired, while ANGPTL4 expression is not downregulated in the absence of ligand. The R314A and T427F mutants are also deficient in basal repression but scored slightly below the cutoff. 4C ). In the presence of TGFβ, repression in cells expressing these mutants was slightly enhanced ( fig. 4D ). Induction by the agonist was again weaker upon expression of the mutants. In further analyses we focused on mutants which showed a loss of basal repression because they allow to distinguish between basal and ligand-mediated repression and are thus suitable for investigation of the ligand-inducible repression mechanism.
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PPARβ/δ mutants defective in basal repression show diminished NCOR and SMRT recruitment to chromatin and increased RNA polymerase II recruitment in the basal state
ChIP-qPCR analysis revealed that the binding of NCOR and SMRT to PPARβ/δ-responsive elements of the ligandresponsive genes ANGPTL4, PDK4, and PLIN2 is markedly reduced in cells that express the T427I, K421A-K422A, and R314A mutants ( fig. 5 ). However, in the presence of PT-S264, NCOR and SMRT binding is also restored by the T427I, K421A-K422A, and R314A mutants. Essentially, the same observation was made for HDAC3 (supp. fig. S8 ). Moreover, binding of RNAPII to the ANGPTL4, PDK4, PLIN2, and ABCA1 target gene TSSs is strongly reduced in PPARD KO cells reconstituted with wt PPARβ/δ ( fig. 6A -D) but not in cells expressing the T427I and K421A-K422A mutants. Strikingly, PT-S264 treatment led to reduced RNAPII binding in cells expressing these mutants. RNAPII binding at the TSC22D3 TSS, which is not a PPAR target gene, was neither affected by expression of the PPARβ/δ-encoding cDNAs nor by PT-S264 ( fig. 6F ). This finding shows that the PPARβ/δ mutants deficient in basal NCOR, SMRT, and HDAC3 binding allow for increased RNAPII occupancy in the absence of activating ligands.
On the other hand, these mutants recruit NCOR, SMRT and HDAC3 in the presence of inverse agonists, and thus RNAPII binding is strongly reduced.
The role of deacetylase activity in repression by PT-S264
To characterise the function of HDAC3 in the repressive mechanism, we treated cells with PT-S264 together with In KO cells with restored wildtype PPARβ/δ expression, PT-S264-mediated repression of ANGPTL4 is insensitive to the HDAC inhibitors, whereas in PPARD KO cells expressing mutants defective in basal repression, repression of ANGPTL4 is partially sensitive to HDAC inhibition ( fig. 7B ). This clearly suggests that the NCOR and SMRT complexes recruited to PPARβ/δ target genes exert both deacetylase-dependent and deacetylase-independent repressive functions; the catalytic activity of HDAC3 contributes to but is not sufficient for full repression. This is in agreement with the observation that ANGPTL4 expression is only weakly induced by HDAC inhibitors ( fig. 7B and [4] ).
In general, weaker repression in 2B3 cells reconstituted with the wildtype PPARD cDNA relative to the parental cells was observed (supp. fig. S6 ). We attribute this to sequestration of corepressors by overexpressed wildtype
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PPARβ/δ, which recruits NCOR and SMRT considerably stronger than the mutants deficient in basal repression ( fig. 5 ). Sequestration might differentially affect the availability of free NCOR and SMRT.
Discussion
NCOR and SMRT figure in gene regulation by a multitude of transcription factors such as the glucocorticoid receptor [38, 39] , other nuclear receptors [7, 40] , POZ-containing, basic helix-loop-helix, and basic leucine zipper factors [41] , the Notch effector RBP-J [42] , and MECP2 (methylated CpG binding protein 2) [43] . Therefore, elucidation of the mechanisms used by NCOR and SMRT complexes is of great interest. We show here that PPARβ/δ inverse agonists interfere with recruitment of Mediator, TFIIB, and RNAPII. PPARβ/δ mutants deficient in NCOR and SMRT recruitment in the basal state allow for enhanced RNAPII binding in the absence of ligands, while the inverse agonist PT-S264 restores both NCOR/SMRT binding to these mutants and loss of RNAPII at target gene promoters. Repression is only partially sensitive to HDAC inhibition, which indicates that NCOR/SMRT complexes exert deacetylase-dependent and deacetylase-independent functions to restrain transcription of PPARβ/δ target genes.
HDAC-independent repression mechanisms exerted by NCOR/SMRT have also been reported in other contexts:
(I) NCOR and SMRT complexes carry out essential functions that are independent of HDAC3 activity [44] , and (II)
HDAC-independent repression of human papillomavirus transcription and replication by NCOR was demonstrated [45] . Moreover, whereas MECP2 represses transcription via an HDAC-independent mechanism [46] , interaction with NCOR/SMRT is crucial for MECP2 function [43] , and it was reported recently that detrimental effects of MECP2 overexpression do not depend on HDAC3 catalytic activity [47] (III).
Our data suggest that deacetylation by HDAC3 contributes to but is not sufficient for basal repression of PPARβ/δ target genes. Thus, an additional enzymatic function of HDAC3-containing complexes or, alternatively, inhibition of an activator-borne enzymatic activity may be required for efficient silencing of gene expression. We speculate that acetyltransferases are inhibited by NCOR and SMRT complexes since (i) acetyltransferase activity is required for transcription in nucleosome-free systems [48] , (ii) GTFs that contribute to reinitiation-TFIIB, TFIIE, and TFIIF-are acetylated in vivo [49, 50] , and (iii) the acetyltransferase activities of CBP and p300 are inhibited by NCOR and SMRT in vitro [51, 52] . Moreover, Mediator interacts with the acetyltransferase-bearing SAGA complex, and both Mediator and SAGA are necessary for RNAPII-mediated transcription in yeast [53, 54, 55] . Partial sensitivity of PT-S264-dependent repression to HDAC inhibitors strongly suggests that NCOR and SMRT recruited by PPARβ/δ use an additional mechanism to restrict activator function. Induction of the PPARβ/δ target gene ANGPTL4 by TGFβ depends on SMAD3 [16] , which interacts with CBP and p300 to activate transcription [56] . CBP and p300 are also paramount coactivators of NFκB [57] and AP-1 [58] transcription factors, which are major targets of transrepression 15/39 by nuclear receptors [39, 58, 59, 60] . These data underscore a possible role for acetyltransferase inhibition in gene regulation by NCOR and SMRT. Since deacetylation and inhibition of acetyltransferase activity act towards the same outcome, the two functions may conceivably act in parallel for more efficient suppression of transcription. Another possibility would be that ubiquitin ligase and deubiquitinase activities which reside in subunits of HDAC3-containing complexes contribute to deacetylase-independent repression. Ubiquitination by TBLR1 [7] could commit activators for degradation, or H2B deubiquitination by USP44 might figure in repression of ANGPTL4 by NCOR/SMRT [61] .
Mediator supports TFIIB binding to promoters, and both Mediator and TFIIB facilitate recruitment of RNAPII to promoter-bound GTFs [31] . This is in line with recent MS data from S.cerevisiae which identifies RNAPII and TFIIB among the strongest interactors of Mediator [53] . Moreover, another recent study revealed that human genes which require de novo RNAPII recruitment for induction of transcription depend on TFIIB availability [62] . It is unclear how transcription factors modulate reinitiation, and in vivo evidence of reinitiation and scaffold complexes is lacking [63] .
Our ChIP data ( fig. 1 ) which demonstrate regulation of Mediator, TFIIB, and RNAPII binding by PPARβ/δ inverse agonists are in agreement with findings obtained from in vitro systems which describe recruitment of RNAPII and TFIIB [19, 31] to scaffold factors and thus may represent in vivo correlates.
It should be noted that we cannot exclude involvement of other corepressors. Genetic deletion of NCOR1 was unsuccessful in two cell lines; this is consistent with the notions that NCOR function may be necessary for regulation of the cell cycle [64] , genome stability [65] , or other critical processes [40] . 
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